Dube Catherine E, Lapane Kate L, Ferrucci Katarina A, Beccia Ariel L, Khan Sara K, Yi Esther, Kay Jonathan, Kuhn Kristine A, Ogdie Alexis, Liu Shao-Hsien
Division of Epidemiology, Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA, 01655, USA.
Clinical and Population Health Research Program, Graduate School of Biomedical Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
Rheumatol Ther. 2021 Jun;8(2):1015-1030. doi: 10.1007/s40744-021-00321-z. Epub 2021 May 31.
On average, patients with axial spondyloarthritis (axSpA) suffer from symptoms up to 13 or more years before diagnosis, contributing to psychological distress and healthcare burden METHODS: We conducted six semi-structured focus groups with 26 axSpA patients (from 3 rheumatology practices located in the states of Massachusetts, Colorado, and Pensylvania, USA) exploring early disease and diagnostic experiences. Verbatim transcripts were coded using a start list with emerging thematic codes added. A qualitative thematic analysis was performed RESULTS: Many participants described meandering and frustrating diagnostic journeys. Participants reported that intermittent axSpA symptoms and idiopathic pain contributed to physician confusion and delay in patients seeking care. Participants were sometimes perceived as somaticizing, drug-seeking, or "crazy." Diagnostic delay led to frustration and mental suffering. Doctors "giving up" was considered profoundly negative. Stories of symptoms fell into five areas: (1) pain; (2) stiffness; (3) impact on sleep; (4) impact on daily activities; and (5) changes with weather. Self-advocacy and family advocacy were considered essential. Participants suggested wider use of HLA-B27 testing and development of a definitive diagnostic test CONCLUSION: Most participants described significant suffering prior to axSpA diagnosis which could have been avoided with earlier intervention. Further research on the early disease experiences of axSpA patients is needed.
平均而言,轴性脊柱关节炎(axSpA)患者在确诊前会出现症状达13年或更长时间,这导致了心理困扰和医疗负担。方法:我们对26名axSpA患者(来自美国马萨诸塞州、科罗拉多州和宾夕法尼亚州的3个风湿病诊疗机构)进行了6次半结构化焦点小组访谈,探讨疾病早期和诊断经历。逐字记录稿使用起始列表进行编码,并添加新出现的主题代码。进行了定性主题分析。结果:许多参与者描述了曲折且令人沮丧的诊断过程。参与者报告称,间歇性的axSpA症状和特发性疼痛导致医生困惑,患者就医延迟。参与者有时被认为是躯体化、寻求药物或“疯狂”的。诊断延迟导致沮丧和精神痛苦。医生“放弃”被认为是极其负面的。症状故事分为五个方面:(1)疼痛;(2)僵硬;(3)对睡眠的影响;(4)对日常活动的影响;(5)随天气变化。自我倡导和家庭倡导被认为至关重要。参与者建议更广泛地使用HLA - B27检测,并开发一种确定性诊断测试。结论:大多数参与者描述了在axSpA诊断之前遭受的重大痛苦,而早期干预本可避免这些痛苦。需要对axSpA患者的疾病早期经历进行进一步研究。